financetom
Business
financetom
/
Business
/
Intellia Therapeutics Names Edward Dulac CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intellia Therapeutics Names Edward Dulac CFO
Jun 26, 2024 5:35 AM

08:08 AM EDT, 06/26/2024 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Wednesday it has named Edward Dulac its chief financial officer, effective July 22.

Dulac will succeed Glenn Goddard, who is stepping down on Sunday, the company said.

Dulac most recently served as Fate Therapeutics' (FATE) CFO.

Price: 24.35, Change: +0.35, Percent Change: +1.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Metsera Closes Initial Public Offering
Metsera Closes Initial Public Offering
Feb 5, 2025
05:42 PM EST, 02/05/2025 (MT Newswires) -- Metsera ( MTSR ) said late Wednesday it has raised about $316.2 million from the initial public offering of its shares, including the exercise of over-allotment option. Shares of the clinical-stage biotechnology company started trading on Nasdaq Jan. 31. ...
Healthpeak Properties' Operating Firm Prices $500 Million Offering of 2035 Notes
Healthpeak Properties' Operating Firm Prices $500 Million Offering of 2035 Notes
Feb 5, 2025
05:45 PM EST, 02/05/2025 (MT Newswires) -- Healthpeak Properties ( DOC ) said late Wednesday its operating company, Healthpeak OP, priced a public offering of $500 million of 5.375% senior unsecured notes due 2035. The price was 99.549% of the principal amount of the notes, the company said. The operating company intends to use the net proceeds to repay borrowings...
Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates
Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates
Feb 5, 2025
Viking Therapeutics, Inc. ( VKTX ) annnounced its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the details from the report.  The Details: Viking Therapeutics ( VKTX ) reported quarterly losses of 32 cents per share, which missed the analyst consensus estimate for losses of 28 cents. The company reported losses of 25 cents per share in the same period last year....
FitLife Brands to Effect 2-for-1 Forward Stock Split
FitLife Brands to Effect 2-for-1 Forward Stock Split
Feb 5, 2025
05:42 PM EST, 02/05/2025 (MT Newswires) -- FitLife Brands ( FTLF ) said late Wednesday it will implement a 2-for-1 forward split of its common shares. The shares will start trading on a split-adjusted basis Friday, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved